GridAI Technologies Corp.
As of Oct 22, 2026, GridAI Technologies is in Stage 2, the uptrend phase, now in week 2 (since Oct 12, 2026). It closed at $5.49, 19.3% below its 52-week high and above its 200-day average, which is rising.
GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power u… More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Setup-score rank among Stage 2 peers: #1 of 110 in Biotechnology · #1 of 272 in Health Care
Is GRDX early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
GRDX among Biotechnology113th of 591 by relative strength
All 591 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | GTBP | Stage 2 · wk 7 | 99 | −22.3% |
| 2 | IOVA | Stage 2 · wk 18 | 99 | +38.8% |
| 3 | SLS | Stage 3 · wk 4 | 99 | −1.5% |
| 4 | MRNA | Stage 2 · wk 17 | 99 | +11.3% |
| 5 | TWST | Stage 2 · wk 39 | 99 | −14.5% |
| 6 | KOD | Stage 2 · wk 4 | 99 | +172.1% |
| 7 | ERAS | Stage 3 · wk 5 | 99 | +0.7% |
| 8 | CLYM | Stage 3 · wk 3 | 99 | −15.8% |
| …113 | GRDX | Stage 2 · wk 2 | 79 | +42.2% |
GridAI Technologies: quick answers
What stage is GridAI Technologies in?
As of Oct 22, 2026, GridAI Technologies (GRDX) is in Stage 2, the uptrend phase. It entered Stage 2 on Oct 12, 2026 and is in week 2. What the four stages mean
Is GridAI Technologies in an uptrend?
Yes. GridAI Technologies is in a Stage 2 uptrend. It trades 57.7% above its 200-day average, which is rising.
How far is GridAI Technologies from its 52-week high?
GridAI Technologies closed at $5.49 on Oct 22, 2026, 19.3% below its 52-week high of $6.80. Its 52-week low is $2.01.
How has GridAI Technologies performed over the past year?
As of Oct 22, 2026, GridAI Technologies is up 35.2% over the past year and up 6.8% so far in 2026.
Which sector and industry is GridAI Technologies in?
GridAI Technologies is in the Biotechnology industry, part of the Health Care sector.
About this companyHealth Care· Biotechnology
GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.